QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
NYSE:NHI

National Health Investors (NHI) Stock Price, News & Analysis

$57.75
+0.16 (+0.28%)
(As of 02/23/2024 ET)
Today's Range
$57.45
$58.07
50-Day Range
$51.61
$57.59
52-Week Range
$47.54
$58.40
Volume
177,247 shs
Average Volume
161,653 shs
Market Capitalization
$2.51 billion
P/E Ratio
18.45
Dividend Yield
6.23%
Price Target
$55.75

National Health Investors MarketRank™ Stock Analysis

Analyst Rating
Hold
2.14 Rating Score
Upside/​Downside
3.5% Downside
$55.75 Price Target
Short Interest
Bearish
1.88% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-2.59
Upright™ Environmental Score
News Sentiment
0.74mentions of National Health Investors in the last 14 days
Based on 19 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
5.29%
From $4.35 to $4.58 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.38 out of 5 stars

Finance Sector

451st out of 858 stocks

Real Estate Investment Trusts Industry

100th out of 180 stocks


NHI stock logo

About National Health Investors Stock (NYSE:NHI)

Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

NHI Stock Price History

NHI Stock News Headlines

Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Q4 2023 National Health Investors Inc Earnings Call
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
National Health Investors (NHI) Q4 FFO Top Estimates
Where National Health Investors Stands With Analysts
Wells Fargo Keeps Their Hold Rating on National Health Investors (NHI)
National Health Investors Inc NHI
See More Headlines
Receive NHI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Health Investors and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/09/2022
Ex-Dividend for 1/26 Dividend
12/28/2023
Dividend Payable
1/26/2024
Today
2/23/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Real estate investment trusts
Sub-Industry
Specialized REITs
CUSIP
63633D10
Employees
25
Year Founded
1991

Price Target and Rating

Average Stock Price Target
$55.75
High Stock Price Target
$69.00
Low Stock Price Target
$50.00
Potential Upside/Downside
-3.5%
Consensus Rating
Hold
Rating Score (0-4)
2.14
Research Coverage
7 Analysts

Profitability

Net Income
$66.40 million
Pretax Margin
42.02%

Debt

Sales & Book Value

Annual Sales
$319.83 million
Cash Flow
$4.98 per share
Book Value
$29.13 per share

Miscellaneous

Free Float
40,258,000
Market Cap
$2.51 billion
Optionable
Optionable
Beta
0.92

Social Links

10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. D. Eric Mendelsohn (Age 62)
    President, CEO & Director
    Comp: $1.21M
  • Mr. John L. Spaid (Age 64)
    Executive VP of Finance, CFO & Treasurer
    Comp: $699.15k
  • Mr. Kevin Carlton Pascoe (Age 43)
    Executive VP & Chief Investment Officer
    Comp: $456.86k
  • Mr. David Louis Travis (Age 49)
    Senior VP & Chief Accounting Officer
    Comp: $484.15k
  • Ms. Kristin Sallee Gaines (Age 52)
    Senior VP & Chief Transaction Officer
    Comp: $564.94k
  • Mr. Dana Rolfson Hambly
    Director of Investor Relations
  • Mr. Kimberly Ouimet
    Director of Corporate Compliance & Human Resources
  • Ms. Michelle R. Kelly
    Senior Vice President of Investments
  • Susan V. Sidwell
    Corporate Secretary
  • Ms. Colleen Schaller
    Real Estate Transaction Manager














NHI Stock Analysis - Frequently Asked Questions

Should I buy or sell National Health Investors stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for National Health Investors in the last year. There are currently 6 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NHI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NHI, but not buy additional shares or sell existing shares.
View NHI analyst ratings
or view top-rated stocks.

What is National Health Investors' stock price target for 2024?

7 analysts have issued 12 month target prices for National Health Investors' shares. Their NHI share price targets range from $50.00 to $69.00. On average, they predict the company's stock price to reach $55.75 in the next twelve months. This suggests that the stock has a possible downside of 3.5%.
View analysts price targets for NHI
or view top-rated stocks among Wall Street analysts.

How have NHI shares performed in 2024?

National Health Investors' stock was trading at $55.85 at the start of the year. Since then, NHI stock has increased by 3.4% and is now trading at $57.75.
View the best growth stocks for 2024 here
.

Are investors shorting National Health Investors?

National Health Investors saw a drop in short interest during the month of January. As of January 15th, there was short interest totaling 742,700 shares, a drop of 14.8% from the December 31st total of 872,100 shares. Based on an average trading volume of 153,000 shares, the short-interest ratio is presently 4.9 days. Currently, 1.8% of the company's shares are sold short.
View National Health Investors' Short Interest
.

When is National Health Investors' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our NHI earnings forecast
.

How were National Health Investors' earnings last quarter?

National Health Investors, Inc. (NYSE:NHI) announced its quarterly earnings results on Monday, May, 9th. The real estate investment trust reported $0.18 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.63 by $0.45. The real estate investment trust had revenue of $71.33 million for the quarter, compared to analyst estimates of $73.06 million. National Health Investors had a trailing twelve-month return on equity of 10.65% and a net margin of 42.40%. The business's quarterly revenue was down 11.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.24 earnings per share.

How often does National Health Investors pay dividends? What is the dividend yield for National Health Investors?

National Health Investors declared a quarterly dividend on Tuesday, February 20th. Stockholders of record on Thursday, March 28th will be given a dividend of $0.90 per share on Friday, May 3rd. This represents a $3.60 dividend on an annualized basis and a yield of 6.23%. The ex-dividend date of this dividend is Wednesday, March 27th.
Read our dividend analysis for NHI
.

Is National Health Investors a good dividend stock?

National Health Investors (NYSE:NHI) pays an annual dividend of $3.60 per share and currently has a dividend yield of 6.34%. NHI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 115.02%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, NHI will have a dividend payout ratio of 78.60% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for NHI.

What guidance has National Health Investors issued on next quarter's earnings?

National Health Investors issued an update on its FY 2024 earnings guidance on Tuesday, February, 20th. The company provided earnings per share guidance of 4.310-4.370 for the period, compared to the consensus estimate of 4.330. The company issued revenue guidance of -.

What other stocks do shareholders of National Health Investors own?

Based on aggregate information from My MarketBeat watchlists, some companies that other National Health Investors investors own include AT&T (T), AbbVie (ABBV), Verizon Communications (VZ), Cisco Systems (CSCO), Annaly Capital Management (NLY), JPMorgan Chase & Co. (JPM), Simon Property Group (SPG), Energy Transfer (ET), QUALCOMM (QCOM) and Broadcom (AVGO).

Who are National Health Investors' major shareholders?

National Health Investors' stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (14.16%), Principal Financial Group Inc. (4.31%), Charles Schwab Investment Management Inc. (1.63%), Dimensional Fund Advisors LP (1.39%), Northern Trust Corp (1.29%) and Lasalle Investment Management Securities LLC (1.08%). Insiders that own company stock include James R Jobe, Robert G Adams and Robert T Webb.
View institutional ownership trends
.

How do I buy shares of National Health Investors?

Shares of NHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:NHI) was last updated on 2/23/2024 by MarketBeat.com Staff